Developing recommendations for prophylaxis and treatment of pregnant women infected with emerging and bioterrorism pathogens can be especially difficult. Data on the effects of some emergency response countermeasure treatments on pregnant women and fetuses are limited. Emergency response planners should include recommendations for pregnant women in pre-event response plans, rather than creating them during an emergency. Clinicians should become familiar with pregnancy-related recommendations for prophylaxis and treatment of persons with emerging and bioterrorism pathogens so that they are prepared to discuss risks and benefits of recommended treatments with their pregnant patients. In an emergency response setting, pregnant women should be encouraged to consider their own health and safety and the effect of potential ill health on their pregnancy, should be offered prenatal evaluation for fetal abnormalities if desired, and should be encouraged to enroll in pregnancy registries when applicable. Long-term goals should include evaluation of the effects of emergency response treatments for the pregnant woman and fetus, and research and development of safer and effective medications when warranted.
Joanne Cono, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, Mailstop D10, 1600 Clifton Rd, Atlanta, GA 30333, USA. Email: firstname.lastname@example.org
Emerging Infectious Diseases. 2006;12(11) © 2006 Centers for Disease Control and Prevention (CDC)
Cite this: Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies - Medscape - Nov 01, 2006.